It's Time for Elon to Earn His $1 Trillion Payday
To collect, Musk has to deliver on his promise to unleash the "mind-blowing" technology Tesla insiders say will push the company into an entirely new market. But with Black Friday chaos sweeping the markets, almost no one sees what's coming. This is the stock we believe stands to benefit from Tesla's next major launch.
AstraZeneca's Investigational Hypertension Drug Shows Significant Blood Pressure Control In Pivotal Trial
AstraZeneca's Baxdrostat cut blood pressure by 14 mmHg in the Phase 3 Bax24 trial, showing strong efficacy and safety in resistant hypertension patients.
Deep in Trump country, coal miners with black lung say government is suffocating the 'working man'
OAK HILL, W.Va. (AP) — Lisa Emery loves to talk about her “boys.” With each word, the respiratory therapist’s face softens and shines with pride. But keep her talking, and it doesn’t take long for that passion to switch to hurt. She knows the names, ages, families and the intimate stories of each one’s scarred lungs. She worries about a whole community of West Virginia coal miners — including a growing number in their 30s and 40s — who come to her for help while getting sicker and sicker from what used to be considered an old-timer’s disease: black lung.
Thanksgiving Special: $19 for Nvidia's Biggest 2026 Moves - Ad
Over $24 trillion is at stake, and Nvidia is in a race to be the first... These companies hold the key to whether they pass or fail. And this weekend only, we are offering an opportunity to score access to Michael's latest picks... for just $19!
Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk
NEW YORK (AP) — U.S. pharmaceutical giant Pfizer signed a deal to purchase development-stage obesity drugmaker Metsera Inc., winning a bidding war against Novo Nordisk, the Danish drugmaker behind weight-loss treatments Ozempic and Wegovy.
Preliminary tests find germ that causes botulism in ByHeart baby formula
Preliminary tests showed that ByHeart baby formula contained the type of bacteria that produces the toxin linked to , California health officials said.
85% Off Proven Crypto Timing Model - This Weekend Only! - Ad
Juan Villaverde's crypto timing model has called every major market turn since 2012. It's now signaling the next big move, and he believes these coins could have big upside. With the market at a critical moment, you can access his latest signals this weekend for just $19.
Baxter Warns Of Potential Device Tampering In Life2000 Ventilator Recall
Baxter recalls its Life2000 ventilators after a cybersecurity flaw prompts an FDA high-risk alert, urging patients to stop use and seek replacement options.
BiomX Awaits FDA Clearance To Restart Cystic Fibrosis Trial After Nebulizer Device Review
BiomX works to address FDA device questions as a safety panel supports the BX004 trial, with topline results now expected in Q2 2026.
Global Demand for Defense Metals Is Surging 7X - Ad
Lithium, uranium and titanium are at the center of a global race. Nations are scrambling to secure them for fighter jets, EVs, and reactors. One N. American project could help fill the West's critical-minerals gap.
Sanofi Faces Surprise HQ Search As French Authorities Expand Tax Probe
Sanofi faces a surprise tax probe in France as Dupixent secures EU approval for treating chronic spontaneous urticaria.
Novo Nordisk Alzheimer's Miss Disappointing But Not Material, Analyst Says
Novo Nordisk stock falls after disappointing results from Alzheimer's trial. Analysts remain cautious about future growth prospects.
This Weekend Only: 3 Partners Enabling Nvidia's $24 Trillion Conquest - Ad
Nvidia is charging into two seismic tech frontiers. But they can't do it alone. Nvidia needs three Silent Partners. Companies so critical, Nvidia's latest trillion-dollar pivot hinges on them. This weekend only, get access to the names of the three companies critical to Nvidia's latest pivot in 2026 for just $19!
Bayer Stroke Drug Hits Trial Goals, Analyst Sees Positive Data Readout From Bristol Myers' Milvexian After Failed Study
Bayer's asundexian cut ischemic stroke risk without more bleeding, boosting FXIa optimism while raising fresh questions for Bristol Myers' milvexian program.
Here's what's next in the fight to curb climate change, now that talks in Brazil have ended
BELEM, Brazil (AP) — After from U.N. climate talks in the Amazon that fell short of many nations' expectations, experts found some bright spots alongside weighty reasons for worry in the fight against .
The End of Tesla? (Black Friday Briefing) - Ad
"Hold onto your Tesla stock." That's the message insiders are sharing as Tesla prepares to unveil a "mind-blowing" new product: one that has nothing to do with EVs... batteries... or self-driving cars. This is a radical pivot that could mark the end of Tesla as we know it and the birth of something much bigger.
Plan for $20 million firefighter training center near the site of Ohio derailment revived
Norfolk Southern railroad worked with the state of Ohio and Youngstown State University to revive plans for a $20 million first responder training center near the site of the in East Palestine, Ohio.
FDA Flags Antibody Risk After Child's Death Linked To Takeda's Enzyme Replacement Therapy For Rare Blood Disorder
FDA reports rare neutralizing antibodies, including a pediatric death, in patients treated with Takeda's Adzynma for congenital TTP.
It's Time for Elon to Earn His $1 Trillion Payday - Ad
To collect, Musk has to deliver on his promise to unleash the "mind-blowing" technology Tesla insiders say will push the company into an entirely new market. But with Black Friday chaos sweeping the markets, almost no one sees what's coming. This is the stock we believe stands to benefit from Tesla's next major launch.
Vanda Reports Big Win In Wegovy Support Study, Analysts Upbeat
Vanda's tradipitant cut Wegovy-related vomiting by 50% in a new trial, prompting bullish analyst views and price targets.
Activist Investor Drops Scathing Letter, Slams Cooper's 'Growth At All Costs' Approach
Browning West urges changes for underperforming Cooper Companies, highlighting weak oversight and misaligned incentives.
Why Is a $116B Mining Giant Backing a $10M Firm? - Ad
Rio Tinto rarely makes early-stage bets. Yet one small N. American firm earned its trust with projects in lithium, uranium, and titanium - all vital to U.S. defense and energy independence.
As infant botulism cases climb to 31, recalled ByHeart baby formula is still on some store shelves
As cases of potentially deadly botulism in babies who drank ByHeart infant formula continue to grow, state officials say they are still finding the on some store shelves.
Guterres and Lula to push negotiators at COP30 as deadline looms
BELEM, Brazil (AP) — Two global power players will spend Wednesday pushing negotiators to find compromises at in Brazil’s Belém, where a self-imposed deadline is rushing up fast.
Legally "Skim" $6,361 Into Your Account? - Ad
A former hedge fund manager is now sharing his "Skim Codes" with regular people. They're not stocks. They're not crypto. They're 18-character codes designed to profit from recent market conditions. All you have to do is punch them into an ordinary brokerage account. 84% of these codes have given people the chance to generate cash payouts so far... and his next code is going out any day now.
Major Victory For Genmab As Epkinly Receives FDA Approval For Type Of Pretreated Blood Cancer
Genmab's Epkinly receives traditional FDA approval for relapsed or refractory follicular lymphoma in combination and monotherapy. Clinical trial data show superior results.
Judge to explain why he's approving Purdue Pharma settlement plan, which calls for $7B from Sacklers
A U.S. Bankruptcy Court judge is set to give his reasoning Tuesday for approving OxyContin maker Purdue Pharma's plan to settle thousands of lawsuits over the toll of opioids.
Cyber Weekend Sale! 85% Off Disruptors and Dominators! - Ad
Nvidia's robot breakthrough, unveiled by CEO Jensen Huang at CES, could spark a $24T revolution. He said the "ChatGPT moment" for robotics is near. I believe the lives of 65M Americans could be impacted - this year. And one $7 stock could be the biggest winner.
AP Lifestyles Digest for week of Nov. 17
Here is the AP Lifestyles Digest for the week of Nov. 17. Note AP's Holiday Gift Guide Digest moved Nov. 12 and is included at the end.
As nations push for more ambition at climate talks, chairman says they may get it
BELEM, Brazil (AP) — Going into , the Brazilian hosts weren’t looking for big end-of-session pronouncements on lofty goals. This conference was supposed to hyperfocus on “implementation” of .
85% Off: Unlock the 5 gold stocks that could surge - Ad
Gold pushed past $4,200, but our expert Sean Brodrick says the real opportunity could lie in a handful of stocks that may soar far beyond gold. He believes the biggest bull market is taking shape and thinks these five companies may have major upside. This weekend only, you can get all five names for just $19.
Climate leaders are talking about 'overshoot' into warming danger zone. Here's what it means
BELEM, Brazil (AP) — The world's climate leaders are conceding that will shoot past a hard limit they set a decade ago in hopes of keeping the planet out of a danger zone. But they're not conceding defeat.
Doritos and Cheetos dial back the bright orange in new versions without artificial ingredients
Doritos and Cheetos are getting a makeover.
Thanksgiving Special: $19 for Nvidia's Biggest 2026 Moves - Ad
Over $24 trillion is at stake, and Nvidia is in a race to be the first... These companies hold the key to whether they pass or fail. And this weekend only, we are offering an opportunity to score access to Michael's latest picks... for just $19!
UK commits to ensuring 'poignant' COVID memorial wall in London will be preserved
LONDON (AP) — The British government said Thursday that a memorial wall in London created by those who lost loved ones during the coronavirus pandemic will be preserved.
Zanzibar’s ‘solar mamas’ are trained as technicians to help light up communities
ZANZIBAR, Tanzania (AP) — When darkness came, so did the smoke.
85% Off Proven Crypto Timing Model - This Weekend Only! - Ad
Juan Villaverde's crypto timing model has called every major market turn since 2012. It's now signaling the next big move, and he believes these coins could have big upside. With the market at a critical moment, you can access his latest signals this weekend for just $19.
Agricultural Conglomerate Bayer Confident In Long-Term Outlook Despite Litigation Risks
Bayer's Q3 earnings rose on strong Crop Science and Pharma sales, with CEO Bill Anderson confident in meeting the company's upgraded 2025 guidance.
Climate change is in the news during COP30. We've got tips to tackle your climate anxiety
Every autumn, news feeds get flooded with stories about . That's because around this time each year, global leaders gather to discuss collective efforts to limit our emissions of planet-warming gases, released primarily from oil, gas and coal.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.